Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Effect of SMYD3 on MDA-MB-231 breast cancer cells (RNA-seq)

ABSTRACT: RNA-sequencing analysis of control and SMYD3-knockdown MDA-MB-231 tumors from the mammary glands of orthotopic xenograft NOD/SCID mice. SMYD3 (also known as KMT3E), a hisone H3 lysine K4 methyltransferase, is highly expressed in several human cancers, including colorectal and breast carcinomas. Results provide insight into the transcriptional regulation of SMYD3 in breast cancer.

ORGANISM(S): Homo sapiens

PROVIDER: GSE129268 | GEO | 2020/06/30

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Similar Datasets

MDA-MB-231 metastasis to human bone

Project description:MDA-MB-231 human breast cancer cells were injected orthotopiclly into mammary glands 4 of female NOD SCID mice 4-weeks after sub-cutaneous implantation of human femoral bone chips. Primary tumour, bone chips containing metastatic deposits and naive bone chips were isolated and mRNA analysed for gene expression to determine genetic signitures associated with breast cancer bone metastasis.

2019-09-24 | GSE137842 | GEO

Effect of SMYD3 on MCF7 breast cancer cells (RNA-seq)

Project description:RNA-sequencing analysis of control and SMYD3-overexpressed MCF7 cell lines. SMYD3 (also known as KMT3E), a hisone H3 lysine K4 methyltransferase, is highly expressed in several human cancers, including colorectal and breast carcinomas. Results provide insight into the transcriptional regulation of SMYD3 in breast cancer.

2022-10-31 | GSE130169 | GEO

Effect of SMYD3 on MDA-MB-231 breast cancer cells (RNA-seq)

Project description:Effect of SMYD3 on MDA-MB-231 breast cancer cells (RNA-seq)

| PRJNA530693 | ENA

Expression data from breast cancer bone metastasis [MDA-MB 231 scp1833]

Project description:The goal of this study was to evaluate genes that are differentially expressed in the bone stroma when breast cancer metastasis are present. We focused our attention on bone stroma cells to understand how the dissemination and growth of tumor cells can impact on the bone environment. Moreover, we aimed to identify potential targets to inhibit the cross talk between cancer cells and tumor microenvironment in bone metastasis. MDA-MB 231 scp1833 breast cancer cell line were engineered to express luciferase and GFP, and injected in NOD-SCID mice by the intracardiac route to obtain bone metastasis. Tumor growth was monitored in-vivo by bioluminescence for 2 weeks. Endothelial cells and osteoblasts were isolated from the long bones of tumor-bearing and tumor-free mice to identify genes differentially expressed.

2017-02-23 | GSE66204 | GEO

Histone methyltransferase SMYD3 knockdown effects in MCF7 breast cancer cell line

Project description:The study aims to elucidate the effect of histone methyltransferase SMYD3 on gene expression in MCF-7 breast cancer cell line. Knockdown luciferase control v.s. knockdown SMYD3 in MCF-7 breast cancer cell line were conducted. Results identify a large proportion of cell cycle-related genes regulated by SMYD3.

2016-11-17 | GSE58048 | GEO

Expression data from MDA-MB-231 derived tumors grown in NOD/SCID mice: control- and Memo1-targeted shRNA pools

Project description:0.5 x10^6 MDA-MB-231 cells, infected with lentivirus encoding either a control shRNA (shLacZ) or a shRNA targeting human Memo1, were injected into the second mammary fatpad of 6-8 week old female NOD/SCID mice and collected 4 weeks after injection.

2015-01-23 | GSE43672 | GEO

Expression data from parental MDA-MB-231 cells and MDA-MB-231(SA) variant

Project description: Not available

| S-ECPF-GEOD-20085 | biostudies-other